Zymergen Inc.
ZYDelisted Oct 19, 2022- Industry
- Services-Commercial Physical & Biological Research
- SEC CIK
- 0001645842
Zymergen Inc. was delisted on Oct 19, 2022; its insiders filed their last Form 4 on Oct 21, 2022; 86 institutions reported holding it in 13F filings for Q3 2022, worth $168.1M in total; ARK Invest was the only superinvestor holding it.
Q4 2021 vs. Q3 2021
How the institutions holding Zymergen Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Of which not filed for Q4 2021 | Q4 2021 | Change |
|---|---|---|---|---|
| Holders | 71 | 1 | 91 | +21 |
| Shares | 50.1M | 70 | 66.3M | +16.3M (+32.5%) |
| Value | $661.3M | $0 | $442.4M | −$218.9M (−33.1%) |
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (34)
Institutions that held Zymergen Inc. at the end of Q4 2021 but not at the end of Q3 2021.
Sold out (13)
Institutions that held Zymergen Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Cota Capital Management, LLC | 989,388 | $13.0M |
| Integral Health Asset Management, LLC | 160,000 | $2.11M |
| Sculptor Capital LP | 53,000 | $698.0K |
| Caas Capital Management LP | 45,180 | $595.0K |
| Ergoteles LLC | 43,588 | $574.0K |
| Russell Investments Group, Ltd. | 42,871 | $564.0K |
| Jump Financial, LLC | 20,355 | $268.0K |
| DuPont Capital Management Corp | 17,963 | $237.0K |
| Johnson & Johnson | 16,553 | $218.0K |
| Ghisallo Capital Management LLC | 15,000 | $198.0K |
| Harbour Investments, Inc. | 600 | $8.00K |
| Brewin Dolphin Ltd | 600 | $7.90K |
| State of Wyoming | 297 | $4.00K |
Not filed for Q4 2021 yet (1)
Institutions that held Zymergen Inc. at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Berman Capital Advisors, LLC | 70 | $0 |